Company Valuation: Madrigal Pharmaceuticals, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,449 5,179 4,568 6,730 13,226 9,247 - -
Change - 257.45% -11.79% 47.33% 96.52% -30.08% - -
Enterprise Value (EV) 1 1,179 4,869 4,051 5,922 12,584 8,612 8,291 7,214
Change - 313.04% -16.81% 46.21% 112.48% -31.56% -3.74% -12.98%
P/E -5.79x -16.8x -11.6x -14.1x -45.3x -231x 57.9x 19.1x
PBR 7.15x 26.6x 11.3x 9x 22.1x 16.4x 11.5x 5.58x
PEG - -0.9x -0.7x -1.48x 1.1x 2.7x -0x 0x
Capitalization / Revenue - - - 37.4x 13.8x 5.84x 4.23x 3.2x
EV / Revenue - - - 32.9x 13.1x 5.44x 3.79x 2.5x
EV / EBITDA -4.87x -16.6x -10.7x -11.9x -42.1x -165x 66.4x 12.3x
EV / EBIT -4.86x -16.6x -10.6x -11.9x -41.9x -186x 39.6x 10.5x
EV / FCF -4.87x -16.6x -12.4x -13x -66.2x -365x 17.9x 8.03x
FCF Yield -20.6% -6.01% -8.04% -7.72% -1.51% -0.27% 5.6% 12.5%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -14.63 -17.23 -19.99 -21.9 -12.85 -1.72 6.877 20.81
Distribution rate - - - - - - - -
Net sales 1 - - - 180.1 958.4 1,584 2,185 2,888
EBITDA 1 -242.1 -293.1 -380 -496.8 -298.6 -52.17 124.8 584.4
EBIT 1 -242.5 -293.6 -380.5 -497.9 -300.1 -46.39 209.6 684.8
Net income 1 -241.8 -295.4 -373.6 -465.9 -288.3 -49.57 215.8 660.3
Net Debt 1 -269.9 -309.5 -517.5 -807.7 -642 -635 -956.7 -2,033
Reference price 2 84.74 290.25 231.38 308.57 582.34 398.08 398.08 398.08
Nbr of stocks (in thousands) 17,097 17,842 19,743 21,810 22,711 23,230 - -
Announcement Date 24/02/22 23/02/23 28/02/24 26/02/25 19/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-231.48x5.44x-165.07x-.--% 9.25B
17.09x6.54x12.53x1.75% 65.45B
31.87x8.51x28.12x0.07% 58.93B
38.62x6.88x20.56x0.84% 55.21B
43.31x6.04x28.76x-.--% 46.1B
33.65x3.22x13.91x-.--% 42.49B
35.05x8.68x22.64x0.37% 35.56B
-18.94x54.62x-20.7x-.--% 34.57B
41.52x8.01x26.86x-.--% 32.46B
-74.21x13.84x-79.52x-.--% 26.28B
Average -8.35x 12.18x -11.19x 0.3% 41B
Weighted average by Cap. 15.76x 11.31x 7.07x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Madrigal Pharmaceuticals, Inc.

Historical PBR trend

Valuation ratios - PBR - Madrigal Pharmaceuticals, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Madrigal Pharmaceuticals, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Madrigal Pharmaceuticals, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Madrigal Pharmaceuticals, Inc.
  1. Stock Market
  2. Stocks
  3. MDGL Stock
  4. Valuation Madrigal Pharmaceuticals, Inc.